The Spanish Competition Authority clears the acquisition of a pharmaceutical company by a rival subject to commitments to abolish rules which require minimum purchase orders and minimum period of permanence (Hefame / Cofarcu)

The CNMC cleared 11 mergers in October* All but one were approved in the first phase and without commitments, as they did not pose problems for competition in the affected markets. The Hefame/Cofarcu merger was approved in the first phase with commitments. The sectors affected by these corporate transactions were the following: pharmaceutical manufacturing, passenger air transport, insurance, reinsurance, pension funds and electricity production, among others. Madrid, 10 October 2022.- The CNMC approved a total of 11 mergers between companies in October. All of them were approved in the first phase and without commitments, with the exception of the Hefame/Cofarcu operation, which required a series of